Abstract:Exercise training induces physiological cardiac hypertrophy, enhanced mitochondrial biogenesis and myocardial contractility. In skeletal muscle, the transcriptional coactivator PGC-1α is a key orchestrator of these responses. The heart expresses abundant and exercise-responsive PGC-1α, but it is unclear whether cardiomyocyte PGC-1α is necessary for cardiac adaptation to endurance training. Here we demonstrate that cardiomyocyte PGC-1α is required for physiological cardiac hypertrophy during exercise training in mice. In the absence of cardiomyocyte PGC-1α, voluntary wheel running does not improve exercise capacity and instead confers immune-fibrotic-atrophic heart failure after just 6 weeks of training. We identify cardiomyocyte PGC-1α as a negative regulator of stress-responsive senescence gene expression. The most enriched of these is the myomitokine GDF15. GDF15 is secreted locally but not systemically in PGC-1α-deficient mouse hearts and reduces cardiomyocyte size. Cardiomyocyte-specific reduction of GDF15 expression preserves exercise tolerance and cardiac contractility in PGC-1α-deficient mice during endurance training. Finally, we show that cardiomyocyte expression correlates with cardiomyocyte number and negatively with GDF15 expression in human cardiomyopathies through single nucleus RNA sequencing. Our data implicate cardiomyocyte PGC-1α as a vital safeguard against stress-induced atrophy and local GDF15-induced dysfunction during exercise.

What problem does this paper attempt to address?

The paper aims to explore the role of PGC-1α (Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha) in cardiomyocytes during endurance training and the impact of its deficiency on cardiac adaptation. Specifically, the researchers aim to answer the following key questions: 1. **Is PGC-1α in cardiomyocytes necessary for the cardiac adaptive response to endurance training?** - The study, using a gene knockout mouse model, found that PGC-1α in cardiomyocytes is crucial for the physiological adaptation of the heart following endurance training. Mice lacking PGC-1α not only failed to improve exercise capacity after endurance training but also developed immune fibrotic heart failure, cardiac atrophy, and accelerated changes in myocardial gene expression. 2. **How does PGC-1α affect the heart's adaptation to endurance training?** - The study discovered that PGC-1α protects the heart from energy stress damage in cardiomyocytes by inhibiting the expression of stress-responsive aging-related genes, particularly by suppressing the expression of GDF15 (Growth Differentiation Factor 15). GDF15 is a locally secreted protein whose increased expression leads to cardiomyocyte atrophy. 3. **What is the role of GDF15 in the absence of PGC-1α in cardiomyocytes?** - The research indicates that the local secretion of GDF15 increases in the hearts of PGC-1α-deficient mice, leading to a decline in cardiac function. Silencing the GDF15 gene via AAV9-mediated delivery significantly improved the exercise endurance and cardiac contractile function of these mice, demonstrating that GDF15 is one of the key factors causing cardiac dysfunction. In summary, this paper primarily addresses the necessity and mechanism of PGC-1α in cardiomyocytes for the cardiac adaptive response to endurance training and reveals the important role of GDF15 in this process. These findings provide new insights into the mechanisms of cardiac adaptation to exercise and may offer new targets for treating diseases related to cardiac dysfunction.

Cardiomyocyte PGC-1α enables physiological adaptations to endurance exercise through suppression of GDF15 and cardiac atrophy